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Objectives. The purpose of this study was to determine how 
frequently prosthetic valve strands are associated with prosthetic 
mitral and aortic valves, as detected by transesophageal echocar- 
diography, and to assess their significance in relation to clinical 
cardioembolic events. 
Background. Strands attached to prosthetic mitral valves are a 
recently described finding of uncertain clinical significance. There 
are no reports of strands attached to aortic valve prostheses, and 
data are limited concerning the relation of valvular strands to 
eardioembolic events. 
Methods. We identified all transesophageal echocardiographic 
studies performed during a 5-year period at our institution for 
evaluation of valve dysfunction or a suspected cardioembolic event 
in patients with a valve prosthesis. All studies were reviewed. The 
presence of strands was noted and the prevalence compared 
between patients evaluated for a suspected cardioembolic event 
and those evaluated for valve dysfunction. In patients with no 
strands detected, the presence of other potential cardiac sources 
of embolism was noted. 
Results. Strands were detected in 56 (26%) of 214 studies. There 
was a significant difference (p = 0.0001) in the prevalence of 
strands between studies performed for a suspected cardioembolic 
event (34 [53%] of 64) versus those performed for suspected valve 
dysfunction (22 [15%] of 150). Strands were more prevalent on 
mitral than on aortic valves (32% vs. 13%, p = 0.0004) and were 
more frequently detected on mechanical than on bioprosthetic 
valves (27% vs. 8%, p = 0.003). Among patients with a suspected 
cardioembolic event and normal valves, other potential cardiac 
sources of embolism were detected in 67%. 
Conclusions. Prosthetic valve strands are frequently detected 
by transesophageal echocardiography. They are more commonly 
detected in patients being evaluated for a suspected cardioembolic 
event and thus represent a potential cardiac source of embolism. 
In patients with apparently normal valves, other potential sources 
of embolism are frequently detected. Thus, transesophageal echo- 
cardiography may have a significant impact on the management of 
these patients. 
(J Am CoU Cardio11995;26:1713-8) 
Approximately 15% to 30% of unexplained focal neurologic 
events are thought o be due to a cardiac source of embolism 
(1). Transesophageal echocardiography as emerged as an 
important imaging modality for evaluating patients with a 
suspected cardioembolic event and has been shown to be 
superior to transthoracic echocardiography in identifying such 
potential intracardiac and extracardiac sources of embolism as 
left atrial thrombi, spontaneous left atrial contrast, aortic 
debris, intracardiac tumors, atrial septal aneurysms, patent 
foramen ovale or atrial septal defects, native valve vegetations 
or strands and prosthetic valve abnormalities (e.g., thrombus 
or vegetations) (2-8). Transesophageal echocardiography is 
also frequently used to assess prosthetic ardiac valves and 
often detects abnormalities not seen by transthoracic echocar- 
diography (9-11). 
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As experience with transesophageal echocardiography 
grows and as image quality improves, more findings of uncer- 
tain clinical significance are being identified. Native and pros- 
thetic valve strands, which appear as highly mobile linear 
echodense structures attached to the valve or sewing ring, are 
one of these findings (8,12,13). 
The purpose of the present study was to determine how 
frequently prosthetic valve strands are associated with mitral 
and aortic valves in patients undergoing transesophageal cho- 
cardiography for the evaluation of a suspected cardioembolic 
event. In addition, we assessed the presence of other potential 
cardiac sources of embolization in patients with a suspected 
cardioembolic event whose prosthetic valves showed no 
strands. Finally, we compared the presence of prosthetic valve 
strands in these patients with that in patients undergoing 
transesophageal chocardiography to evaluate suspected pros- 
thetic valve dysfunction. 
Methods  
Patient identification. All transesophageal eehocardio- 
graphic studies performed at our institution in patients with 
prosthetic ardiac valves over a 5-year period (October 1989 
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through November 1994) were identified from a computerized 
data base in our laboratory. During the study period, a total of 
359 transesophageal echocardiographic studies performed in 
patients with prosthetic valves were available for review; an 
additional 10 studies performed uring this period were not 
available for review. Intraoperative studies were excluded from 
consideration. All studies were performed for clinical indica- 
tions and written informed consent was obtained for each 
study. Clinical and demographic information, and the indica- 
tion for the transesophageal echocardiogram were obtained 
from a review of the echocardiography consultation form and 
the clinical history documented on the final clinical report. 
To avoid the possibility of identifying small vegetations as 
strands, we subsequently excluded transesophageai echocar- 
diographic studies performed inpatients because of suspected 
prosthetic valve endocarditis and follow-up studies performed 
to reassess previously documented valve abnormalities. The 
current study thus included a total of 214 studies performed 
because of a suspected cardioembolic event, prosthetic valve 
dysfunction or non-valve-related in ications in 182 patients 
with a mitral or aortic prosthetic valve, or both. 
Echocardiography. Transesophageal echocardiography 
was performed in a standardized fashion with commercially 
available quipment (14). The majority of studies were per- 
formed with a Hewlett-Packard single plane (model 21362A), 
biplane (model 21363A) or multiplane (model 21364A) probe 
in conjunction with a Hewlett-Packard Sonos 500, 1000 or 1500 
imaging system. Several studies done early in the series were 
performed with an ATL single plane probe using an ATE 
Ultramark 9 imaging system (Advanced Technologies Labora- 
tory). Patients were studied after a fast of ->4 h. Transesoph- 
ageal echocardiography was performed after administration f 
local pharyngeal nesthesia with a topical lidocaine or Ceta- 
caine (Cetalyte Industries) pray and intravenous sedation with 
midazolam or meperidine, or both, as needed. Patients who 
were not being treated with antibiotics were given antibiotic 
prophylaxis according to the recommendations f the Ameri- 
can Heart Association (15,16). All studies were recorded on 
videotape for subsequent review. No complications attribut- 
able to the procedure were reported. 
Strands. Prosthetic valve strands were defined as mobile 
linear echodense structures attached to the valve sewing ring, 
struts or hinge points (Fig. 1). They are typically 1 to 2 mm in 
width and several mm in length. Strands are distinct from 
larger valvular masses uch as thrombus or vegetations. They 
were differentiated from loose sutures, which tend to be 
shorter, brighter and spaced regularly around the sewing ring. 
These strands are also different from prosthetic valve micro- 
bubbles, which appear as bright, highly mobile echoes that 
move rapidly away from the valve at the time of valve closure, 
whereas trands are fixed to the valve and are seen in the same 
position on the valve from beat to beat (17). 
Eehoeardiographic review. All transesophageal echocar- 
diographic studies were independently reviewed by an experi- 
enced echocardiographer who had no knowledge of the pa- 
tient's clinical status. The reviewer determined the presence or 
Figure 1. Transesophageal echocardiogram demonstrating prosthetic 
valve strands (arrows) attached toa St. Jude mitral valve. 
absence of prosthetic valve strands and analyzed the study with 
regard to prosthetic valve function, presence of left atrial 
spontaneous contrast and global eft ventricular function. This 
interpretation f the echocardiogram was then compared with 
the clinical report generated by the physician who performed 
and interpreted the study. Disagreements were resolved by 
consensus. 
Statistics. Continuous variables are expressed as mean 
value _+ SD. Dichotomous variables were compared by using 
contingency table and chi-square analysis. A p value < 0.05 
was considered statistically significant. 
Results  
Over the 5-year study period, a total of 214 transesophageal 
echocardiographic studies were performed in 182 patients with 
a prosthetic valve for the evaluation of a suspected cardiac 
source of embolus, suspected prosthetic valve dysfunction or 
miscellaneous non-valve-related in ications. Patients under- 
went 1 to 4 studies (mean 1.2 _+ 0.5). The patients had a mean 
age of 55 -+ 15 years; 45% were men. 
Sixty-four of the 214 studies were performed in59 patients 
to evaluate a possible cardiac source of embolization. The 
other 150 studies were performed in 133 patients to evaluate 
the prosthesis because of new or changing symptoms (135 
studies) or non-valve-related in ications (15 studies). Thus, 10 
patients underwent a transesophageal chocardiogram for 
both indications. Because of the small number of studies 
performed for miscellaneous reasons (n = 15), subsequent 
analysis was performed comparing the 64 studies assessing 
patients for a cardiac source of embolization with the remain- 
ing 150 studies. 
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Prevalence of strands. Prosthetic valve strands were de- 
tected in 56 (26%) of the 214 studies. Of the 64 studies 
performed to evaluate acardiac source of embolization, pros- 
thetic valve strands were found in 34 (53%). In contrast, 
strands were detected in only 22 (15%) of the 150 remaining 
studies (p -- 0.0001). Patients tudied to evaluate a possible 
cardiac source of embolization were more likely to have a 
mechanical valve than were patients being evaluated for sus- 
pected prosthetic valve dysfunction or miscellaneous reasons 
(89% vs. 70%, p = 0.003). In addition, studies in patients with 
a mechanical valve were significantly more likely to show 
prosthetic valve strands than were studies in patients with a 
bioprosthetic valve (31% vs. 10%, p -- 0.002). 
To exclude the possibility that the association of strands 
with cardioembolic events merely reflected a higher prevalence 
of mechanical prostheses in our study patients, we analyzed the 
studies of mechanical nd bioprosthetic valves separately. Of 
the 162 studies in patients with a mechanical valve, strands 
were detected in 32 (56%) of 57 studies performed for a 
cardioembolic event compared with 19 (18%) of the remaining 
105 studies (p = 0.0001). Of the 52 studies in which only a 
bioprosthetic valve was present, strands were detected in 2 
(29%) of 7 studies performed for a cardioembolic event 
compared with 3 (7%) of the 45 remaining studies (p = 0.07). 
In 34 studies, both an aortic and a mitrai valve prosthesis 
were present. Thus, a total of 248 valves (130 mitral and 118 
aortic) were evaluated, and strands were detected on 56 (23%) 
of the 248 valves. As in the preceding analysis of results by 
study, a similar analysis of all valves by indication for study 
revealed that strands were significantly more likely (p = 
0.0001) to be detected on valves studied for a cardioembolic 
event (34 [47%] of 72) than on the remaining valves being 
evaluated (22 [13%] of 176). 
Strands were detected on 41 mitral valves (32%) compared 
with 15 aortic valves (13%) (p = 0.0004). Strands were more 
frequently detected on mechanical than on bioprosthetic valves 
(27% vs. 8%, p = 0.003). Figure 2 depicts the prevalence of 
strands by valve location and type. Subgroup analysis of the 
prevalence of strands by valve location and type (mechanical 
vs. bioprosthetic) revealed a greater prevalence of strands on 
valves being evaluated for a potential cardiac source of embo- 
lism than on the remaining valves studied (Table 1). 
A total of 26 patients underwent more than one study. To 
eliminate the assessment of a given valve more than once, the 
results were reanalyzed by entering only the first study per- 
formed, regardless of indication or presence of valvular 
strands, or both, into the analysis. Of the 182 initial studies, 53 
were performed for a cardiac source of embolism and 129 to 
assess the prosthetic valve or for miscellaneous reasons. A total 
of 212 individual valves (108 mitral and 104 aortic prostheses) 
were studied in the 182 patients. As in the analysis of the 
overall study group, strands were significantly more common 
(p = 0.0001) in studies performed to evaluate a cardioembolic 
event (28 [53%] of 53) than in the remaining studies (18 [14%] 
of 129). In addition, the analysis concerning the prevalence of 
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Figure 2. Bar graphs depicting the prevalence of valve strands by 
prosthetic valve type for all valves tudied (top, n = 248), mitral 
prostheses (center, n = 130) and aortic prostheses (bottom, n = 118). 
Numbers in parentheses under each valve type represent total number 
of valves evaluated. BIO = bioprosthetic; BS = Bjork-Shiley; MH = 
Medtronic Hall; Other = other valve types; SE = Starr-Edwards; SJ = 
St. Jude. 
strands when assessed by valve type and location (data not 
shown) was similar to the overall analysis described earlier. 
Patients with multiple studies. A total of 26 patients 
underwent multiple studies. In 20 patients (42 studies), strands 
were either present (5 patients, 10 studies) or absent (15 
patients, 32 studies) in all studies performed. Discordant 
results (i.e., strands present in some but not all studies) were 
noted in the other six patients (16 studies). In three patients 
(eight studies) evaluated on all occasions for suspected pros- 
thetic valve dysfunction, strands were detected in one study in 
each and absent in all other studies. The remaining three 
patients underwent eight studies; strands were detected in 
three of the five studies performed to rule out a cardiac 
etiology of a suspected embolic event, whereas no strands were 
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Table 1. Prevalence ofStrands by Valve Type and Location for 
Each Indication 
Indication for Study 
Valve Type CSE PVD/Misc p Value 
All mechanical (n = 189) 32,/64 (50%) 19/125 (15%) 0.0001 
All bioprosthetic (n = 59) 2,/8 (25%) 3/5l (6%) 0.07 
Mitral mechanical (n = 95) 23/35 (66%) 15/60 (25%) 0.0001 
Mitral bioprosthetic (n = 35) l/3 (33%) 2/32 (6%) NS 
Aortic mechanical (n - 94) 9/29 (31c~) 4/65 (6%) 0.001 
Aortic bioprosthetic (n = 24) l/5 (20c:,~) 1/19 (5%) NS 
Data are presented as total number of each type of valve with strands/total 
number evaluated (percent of total) for each indication. CSE = cardiac source 
of embolism; Misc = miscellaneous non-valve-related indications; PVD = 
prosthetic valve dysfunction. 
detected in two of the three studies performed for suspected 
prosthetic valve dysfunction. 
Findings in patients with a normal prosthesis. Of the 30 
studies performed in patients with a suspected cardioembolic 
event in whom no strands were detected on the prosthesis, 20 
showed other abnormalities that have been associated with 
systemic embolization, including definite sources of embolism 
in 6 studies (left atrial thrombus in 3, unsuspected prosthetic 
mitral valve vegetations in 2 and prosthetic valve thrombus in 
1). Possible sources of embolism included spontaneous left 
atrial contrast in eight studies, an atrial septal defect or patent 
foramen ovale in five, atrial septal aneurysm in two, mitral 
valve prolapse in two and aortic atherosclerosis (plaque) in 
seven. In eight studies (including three of the studies with 
definite sources of embolism), more than one potential cardiac 
source of embolism was detected. 
Representative cases: surgical-pathologic orrelation. We 
have surgical and pathologic data on three patients who 
underwent valve replacement for repeated cardioembotic 
events. All three patients had a transesophageal echocardio- 
gram that demonstrated prosthetic valve strands. A fourth 
patient is described to highlight he utility of transesophageal 
echocardiography in this patient group even if no strands are 
detected. 
Patient I. This 49-year old man with a 10-year old Starr- 
Edwards mitral prosthesis had a history of multiple cerebral 
embolic events despite adequate anticoagulation. Transesoph- 
ageal echocardiography demonstrated prosthetic valve strands 
(Fig. 3). He underwent valve replacement. At operation, the 
surgeon described "filamentous strands of fibrous material 
bridging the struts of the cage" that were consistent with the 
transesophageal chocardiographic findings. The pathology 
report described "thrombus and fibrous material" on the sewing 
ring, small fragments of "friable soft tissue" on the outflow 
surface of the valve and soft tissue attached to the valve sewing 
ring. 
Patient 2. This 42-year old man presented with multiple 
transient ischemic attacks that were thought to be cardioem- 
bolic in origin. Transesophageal echocardiography on two 
Figure 3. Strand (arrow) attached to the Starr-Edwards mitral valve of 
a patient with multiple cerebral embolic events. At operation, "fila- 
mentous strands of fibrous material" were described by the surgeon. 
occasions 1month apart demonstrated multiple mobile strands 
attached to his Starr-Edwards mitral valve. He underwent 
valve replacement and has since done well with no repeated 
events. At operation, the surgeon described "fronds of mate- 
rial and calcification over the atrial surface of the sewing ring," 
with "frayed cloth" present. The pathology report noted 
pannus formation on the cage and sewing ring. 
Patient 3. A 39-year old woman with a 3-year old Starr- 
Edwards mitral prosthesis presented with a transient ischemic 
attack. A transesophageal chocardiogram demonstrated pros- 
thetic valve strands attached to the medial and lateral aspects 
of the sewing ring. The patient had repeated transient ischemic 
attacks. A second transesophageal chocardiogram, performed 
4 months later, demonstrated persistence of the strands de- 
spite therapeutic prothrombin times. She underwent valve 
replacement, and at the time of operation, the surgeon de- 
scribed "a large ring of clot around the prosthesis." However, 
the pathology report described no thrombus or pannus. Since 
the operation she has done well with no further neurologic 
events. 
Patient 4. This 61-year old man with a Start-Edwards mitral 
prosthesis underwent four serial transesophageal choeardio- 
grams. On the initial study, performed to assess possible 
prosthetic valve dysfunction, the valve appeared normal. The 
second study, performed 9 months later after a transient 
ischemic attack in the setting of a therapeutic prothrombin 
time, demonstrated strands attached to the valve. Dipyridam- 
ole was added to the patient's regimen and a repeat rans- 
esophageal echocardiogram, performed 6 weeks later, showed 
no strands on the valve. This patient had another transient 
ischemic attack several months later, and repeat ransesopha- 
geal echocardiography demonstrated a normal prothesis. 
Spontaneous left atrial contrast, seen on prior studies, was still 
present, and a new left atrial appendage thrombus was de- 
tected. 
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Discussion 
With the increasing use of transesophageal chocardiogra- 
phy for evaluation of prosthetic cardiac valves, it has become 
more important to understand the normal appearance of these 
valves and to differentiate subtle abnormalities from normal 
findings. Several studies (9-11,18,19) have described the nor- 
mal appearance and function of prosthetic valves as assessed 
by transesophageal chocardiography and have demonstrated 
an increased sensitivity over transthoracic e hocardiography in 
the detection of prosthetic valve abnormalities. 
Comparison with prior studies. Valve strands detected on 
prosthetic valves are a recently described finding of uncertain 
clinical significance (12,13,20,21). Stoddard et al. (12) reported 
on their prevalence in 13 patients with a St. Jude mitral valve 
who underwent 26 transesophageal chocardiographic studies. 
Strands were present on 38% (5 of 13) of the valves at the time 
of initial study. Five patients with initially negative findings on 
transesophageal echocardiography underwent serial trans- 
esophageal echocardiographic studies; prosthetic valve strands 
were subsequently detected in four of these patients. Thus, 9 
(69%) of 13 patients had mitral valve strands detected on at 
least one occasion. No relation between strands and cerebral 
emboli was reported. 
Isada et al. (13) reported on 76 patients with a prosthetic 
mitral valve who underwent 83 transesophageal chocardio- 
graphic studies. Prosthetic mitral valve strands were detected 
in 18% of all studies and were significantly more frequent on 
mechanical valves. Of the 83 studies, 71 were performed to 
assess valve function; only 7 were performed specifically to 
detect a cardiac source of embolism. Strands were detected 
more frequently on mechanical valves. These authors reported 
an association of strands with embolic events, but only seven 
studies were performed to specifically evaluate the patient for 
a cardioembolic event. 
In a recent report on "nonobstructive thrombosis" ofmitral 
prostheses (22), small thrombi were detected on 18% of 114 
mitral valves studied for a variety of reasons. An association 
between these thrombi and embolic events was reported. 
Whether some of these thrombi represented strands cannot be 
ascertained from the description of the findings in that report. 
In the current study, we detected strands in 26% (56 of 214) 
of studies in a group of patients undergoing transesophageal 
echocardiography for the evaluation of a suspected cardioem- 
bolic event, suspected prosthetic valve dysfunction or non- 
valve-related indications. This represented a prevalence of 
strands in 23% of all individual valves tudied. Unlike a prior 
study (13), our study compared the prevalence of strands in 
patients pecifically undergoing echocardiography to evaluate 
a suspected cardioembolic event with that of patients being 
studied for other indications, and we found a significantly 
greater prevalence of strands in the former group. Strands 
were more common in patients with a suspected cardioembolic 
event than in those studied for other indications among 
patients with a mechanical valve and among those with a 
bioprosthetic valve. 
Previously published reports have been limited to studies of 
mitral valve prostheses. In the present study, 15 (63%) of 24 St. 
Jude mitral valves had strands, aprevalence of strands imilar 
to that reported by Stoddard et al. (12). In this study we also 
described differences in the prevalence of strands between 
mechanical nd bioprosthetic valves, as well as among different 
types of mechanical valves. 
The present study is the first to report on the presence of 
strands on aortic valves. Strands were more frequently de- 
tected on mitral than on aortic valves. This finding may reflect 
a true difference in the prevalence of strands on mitral versus 
aortic prostheses or may merely be due to better visualization 
of mitral than aortic valves by transesophageal chocardiogra- 
phy. As with mitral prostheses, trands on aortic prostheses 
were more often detected on mechanical than on bioprosthetic 
valves and in studies performed to evaluate a suspected 
cardioembolic event than in those performed for other rea- 
sons. 
Clinical implications. The present study highlights the 
important role that transesophageal chocardiography may 
play in the evaluation and management of patients with 
prosthetic valves who have an embolic event, which is often 
ascribed to the valve. A study demonstrating a normal valve 
may exculpate the valve as a source of embolism and thus 
preclude potentially unwarranted valve replacement. This may 
be especially true if another potential source of embolism is 
detected, as was the case in 67% of our patients, including six 
patients (20%) who were found to have a definite source of 
embolism. In contrast, persistence of strands in association 
with repeated events, as was demonstrated in three patients in 
our series, may lead to valve replacement as a therapy to 
prevent recurrence. 
Although limited, the present study does provide some 
correlation between strands detected by transesophageal cho- 
cardiography and surgical-pathologic data. In contrast o a 
previous tudy (13) that reported no surgical or pathologic data 
consistent with strands in patients who underwent valve re- 
placement, our study did find evidence at operation or patho- 
logic study of findings consistent with the transesophageal 
echocardiographic description of strands. These strands may 
therefore represent fibrin, small thrombus or pannus forma- 
tion. When detected in patients with a cardioembolic event, 
intensification of anticoagulant therapy or the addition of 
antiplatelet agents, or both, may be warranted. These strands 
are a potential cardiac source of embolism, given the strong 
association with cardioembolic events. Because their natural 
history is unknown, it is not clear how best to manage patients 
in whom strands are detected uring studies for other indica- 
tions. These patients warrant careful follow-up and perhaps 
more aggressive antithrombotic reatment as well. 
Limitations. The present study has several important lim- 
itations. First, it was a retrospective study and we have 
incomplete information regarding the prosthetic valves (e.g., 
valve age or size) as well as limited clinical information, such as 
the patients' anticoagulation status and anti-platelet therapy. 
Also, these patients were studied for a suspected cardiac 
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source of embolization and may have had a noncardioembolic 
origin of their clinical event. Follow-up data on these patients 
are minimal. Finally, we have limited surgical or pathologic 
data on valves with strands. The pathologic data available are 
not entirely consistent with either the echocardiographic or 
surgical appearance of the valves and there is no confirmation 
as to the composition of the strands. We also cannot exclude 
the possibility that strands were detected with greater fre- 
quency because patients tudied for cardioembolic events may 
have had a more meticulous examination of the prosthesis n 
search of strands. This is unlikely as the findings reported are 
similar to the results in the first 91 studies initially analyzed 
before the potential clinical significance of strands was recog- 
nized. 
Despite these limitations, the significantly greater preva- 
lence of strands in patients undergoing transesophageal cho- 
cardiography for a suspected cardiac source of embolization 
suggests that prosthetic valve strands are related to the pa- 
tients' clinical presentation and represent a potential cardiac 
source of embolization. Alternatively, strands may be a marker 
for another process that results in systemic embolization. 
Conclusions. Among patients with a prosthetic ardiac 
valve, strands attached to the valve are found significantly 
more often in those with a suspected cardioembolic event han 
in those being evaluated for other indications. These strands 
may indicate an abnormal valve with thrombus, fibrin or 
pannus formation and would appear to have a high potential 
for systemic embolization. In patients with apparently normal 
valves, transesophageal echocardiography may detect other 
potential cardiac sources of emboli and thus may alter patient 
management. 
We thank Robyn Dozier, RN and Nancy Palnick, RN for assistance in perfor- 
mance of the transesophageal chocardiographic studies, Peter Gray, BA for 
assistance in data collection and Teresa Mrkvicka Henderson for assistance in 
manuscript preparation. 
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